PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $64,000 | +60.0% | 19,745 | +45.0% | 0.00% | – |
| Q4 2018 | $40,000 | -53.5% | 13,621 | -58.1% | 0.00% | -100.0% |
| Q3 2018 | $86,000 | -47.2% | 32,525 | -53.4% | 0.00% | 0.0% |
| Q2 2018 | $163,000 | +232.7% | 69,869 | +403.2% | 0.00% | – |
| Q4 2015 | $49,000 | -79.3% | 13,885 | -56.2% | 0.00% | -100.0% |
| Q3 2014 | $237,000 | +70.5% | 31,686 | +81.1% | 0.00% | +100.0% |
| Q3 2013 | $139,000 | – | 17,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |